BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21681016)

  • 1. Pharmacogenetics of β2-agonists.
    Hizawa N
    Allergol Int; 2011 Sep; 60(3):239-46. PubMed ID: 21681016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-2 adrenergic receptor genetic polymorphisms and asthma.
    Hizawa N
    J Clin Pharm Ther; 2009 Dec; 34(6):631-43. PubMed ID: 20175796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenoceptor responses of the airways: for better or worse?
    Broadley KJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease.
    Vacca G; Schwabe K; Dück R; Hlawa HP; Westphal A; Pabst S; Grohé C; Gillissen A
    Ther Adv Respir Dis; 2009 Feb; 3(1):3-10. PubMed ID: 19293197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients.
    Yelensky R; Li Y; Lewitzky S; Leroy E; Hurwitz C; Rodman D; Trifilieff A; Paulding CA
    Pharmacogenomics J; 2012 Dec; 12(6):484-8. PubMed ID: 22158330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma.
    Taylor DR; Epton MJ; Kennedy MA; Smith AD; Iles S; Miller AL; Littlejohn MD; Cowan JO; Hewitt T; Swanney MP; Brassett KP; Herbison GP
    Am J Respir Crit Care Med; 2005 Sep; 172(6):700-3. PubMed ID: 15976384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
    Peters S
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic tests in asthma therapy.
    Yu IW; Bukaveckas BL
    Clin Lab Med; 2008 Dec; 28(4):645-65. PubMed ID: 19059068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
    Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
    J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma.
    Chung LP; Waterer G; Thompson PJ
    Clin Exp Allergy; 2011 Mar; 41(3):312-26. PubMed ID: 21294785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.
    Hizawa N; Makita H; Nasuhara Y; Betsuyaku T; Itoh Y; Nagai K; Hasegawa M; Nishimura M
    Chest; 2007 Nov; 132(5):1485-92. PubMed ID: 17890463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta2-adrenoceptor polymorphisms and obstructive airway diseases: important issues of study design.
    Yang IA; Ng T; Molenaar P; Fong KM
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1029-36. PubMed ID: 17714090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management.
    Ortega VE
    Clin Genet; 2014 Jul; 86(1):12-20. PubMed ID: 24641588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta 2 adrenergic receptor polymorphisms in cystic fibrosis.
    Hart MA; Konstan MW; Darrah RJ; Schluchter MD; Storfer-Isser A; Xue L; Londono D; Goddard KA; Drumm ML
    Pediatr Pulmonol; 2005 Jun; 39(6):544-50. PubMed ID: 15806595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review.
    Slob EMA; Vijverberg SJH; Palmer CNA; Zazuli Z; Farzan N; Oliveri NMB; Pijnenburg MW; Koppelman GH; Maitland-van der Zee AH
    Pediatr Allergy Immunol; 2018 Nov; 29(7):705-714. PubMed ID: 29992699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics of long-acting β2-agonists.
    Blake K; Lima J
    Expert Opin Drug Metab Toxicol; 2015; 11(11):1733-51. PubMed ID: 26235677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β(2) -adrenoreceptor polymorphisms in asthmatic and non-asthmatic schoolchildren from Colombia and their relationship to treatment response.
    Isaza C; Sepúlveda-Arias JC; Agudelo BI; Arciniegas W; Henao J; Porras GL; Beltrán L
    Pediatr Pulmonol; 2012 Sep; 47(9):848-55. PubMed ID: 22328447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is new with the beta2-agonists: issues in the management of asthma.
    Kelly HW
    Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response.
    Nielsen AO; Jensen CS; Arredouani MS; Dahl R; Dahl M
    COPD; 2017 Aug; 14(4):451-460. PubMed ID: 28506092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.